BioNTech SE ADR falls Wednesday, underperforms market
The BioNTech SE ADR BNTX slipped 7.29% to $115.62 Wednesday, on what proved to be an all-around rough trading session for the ...
UBS Keeps Their Hold Rating on BioNTech SE (BNTX)
UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The ...
Hosted on MSN19h
IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
TG Therapeutics stock popped Wednesday after the company unveiled promising five-year test results for its multiple sclerosis ...
gastroenterologyadvisor20h
FDA OKs KP.2-Adapted COVID-19 Vaccines for 2024-2025 Season
Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...
In Depth
Mayo Clinic on MSN20hIn Depth
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...